Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer ; volume:11 ; number:1 ; day:6 ; month:6 ; year:2011 ; pages:1-9 ; date:12.2011
BMC cancer ; 11, Heft 1 (6.6.2011), 1-9, 12.2011
- Creator
-
Heinemann, Lucy
- Contributor
-
Simpson, Guy R.
Boxall, Angela
Kottke, Timothy
Relph, Kate L.
Vile, Richard
Melcher, Alan
Prestwich, Robin
Harrington, Kevin J.
Morgan, Richard
Pandha, Hardev S.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-221
- URN
-
urn:nbn:de:1111-2016030362227
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heinemann, Lucy
- Simpson, Guy R.
- Boxall, Angela
- Kottke, Timothy
- Relph, Kate L.
- Vile, Richard
- Melcher, Alan
- Prestwich, Robin
- Harrington, Kevin J.
- Morgan, Richard
- Pandha, Hardev S.
- SpringerLink (Online service)
Other Objects (12)
Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
Effectiveness and Feasibility of Up-Front Docetaxel Chemotherapy for Japanese Metastatic Hormone-Naïve Prostate Cancer
Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy
Nail changes secondary to docetaxel chemotherapy : a case report
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report
Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
Effectiveness and Feasibility of Up-Front Docetaxel Chemotherapy for Japanese Metastatic Hormone-Naïve Prostate Cancer
Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy
Nail changes secondary to docetaxel chemotherapy : a case report
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report
Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
Effectiveness and Feasibility of Up-Front Docetaxel Chemotherapy for Japanese Metastatic Hormone-Naïve Prostate Cancer
Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy
Nail changes secondary to docetaxel chemotherapy : a case report
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report
Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells